Sperm count is increased by diet-induced weight loss and maintained by exercise or GLP-1 analogue treatment: a randomized controlled trial

Emil Andersen, Christian R Juhl, Emma T Kjøller, Julie R Lundgren, Charlotte Janus, Yasmin Dehestani, Marte Saupstad, Lars R Ingerslev, Olivia M Duun, Simon B K Jensen, Jens J Holst, Bente M Stallknecht, Sten Madsbad, Signe S Torekov, Romain Barrès, Emil Andersen, Christian R Juhl, Emma T Kjøller, Julie R Lundgren, Charlotte Janus, Yasmin Dehestani, Marte Saupstad, Lars R Ingerslev, Olivia M Duun, Simon B K Jensen, Jens J Holst, Bente M Stallknecht, Sten Madsbad, Signe S Torekov, Romain Barrès

Abstract

Study question: Does diet-induced weight loss improve semen parameters, and are these possible improvements maintained with sustained weight loss?

Summary answer: An 8-week low-calorie diet-induced weight loss was associated with improved sperm concentration and sperm count, which were maintained after 1 year in men who maintained weight loss.

What is known already: Obesity is associated with impaired semen quality. Weight loss improves metabolic health in obesity, but there is a lack of knowledge on the acute and long-term effects of weight loss on semen parameters.

Study design, size, duration: This is a substudy of men with obesity enrolled in a randomized, controlled, double-blinded trial (the S-LITE trial). The trial was conducted between August 2016 and November 2019. A total of 56 men were included in the study and assigned to an initial 8-week low-calorie diet (800 kcal/day) followed by randomization to 52 weeks of either: placebo and habitual activity (placebo), exercise training and placebo (exercise), the Glucagon Like Peptide 1 (GLP-1) analogue liraglutide and habitual activity (liraglutide) or liraglutide in combination with exercise training (combination).

Participants/materials, setting, methods: Inclusion criteria were men who delivered semen samples, 18 to 65 years of age, and a body mass index between 32 and 43 kg/m2, but otherwise healthy. The study was carried out at Hvidovre Hospital and at the University of Copenhagen, and the participants were from the Greater Copenhagen Area. We assessed semen parameters and anthropometrics and collected blood samples before (T0), after the 8-week low-calorie dietary intervention (T1), and after 52 weeks (T2).

Main results and the role of chance: The men lost on average 16.5 kg (95% CI: 15.2-17.8) body weight during the low-calorie diet, which increased sperm concentration 1.49-fold (95% CI: 1.18-1.88, P < 0.01) and sperm count 1.41-fold (95% CI: 1.07-1.87, P < 0.01). These improvements were maintained for 52 weeks in men who maintained the weight loss, but not in men who regained weight. Semen volume, sperm motility and motile sperm count did not change.

Limitations, reasons for caution: The S-LITE trial was a randomized controlled trial of weight loss maintenance. Analysis of semen was preregistered to explore the effects of weight loss and weight loss maintenance on semen parameters, but definite inferences cannot be made.

Wider implications of the findings: This study shows that sperm concentration and sperm count were improved after a diet-induced weight loss in men with obesity. Our findings indicate that either or both liraglutide and exercise as weight maintenance strategies may be used to maintain the improvements in sperm concentration and count.

Study funding/competing interest(s): This work is supported by an excellence grant from the Novo Nordisk Foundation (NNF16OC0019968), a Challenge Programme Grant from the Novo Nordisk Foundation (NNF18OC0033754) and a grant from Helsefonden. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research centre at the University of Copenhagen, partially funded by an unrestricted donation from the Novo Nordisk Foundation (NNF18CC0034900). Saxenda (liraglutide) and placebo pens were provided by Novo Nordisk. Cambridge Weight Plan diet products for the 8-week low-calorie diet were provided by Cambridge Weight Plan. E.A.: shareholder, employee of ExSeed Health Ltd. Grant Recipient from ExSeed Health Ltd and listed on Patents planned, issued or pending with ExSeed Health Ltd; J.J.H.: consultant for Eli Lilly A/S and Novo Nordisk A/S. Lecture fees for Novo Nordisk A/S. Listed on Patents planned, issued or pending with the University of Copenhagen, Advocacy group for Antag Therapeutics and Bainan Biotech; S.M.: lecture fees for Novo Nordisk A/S. Recipient of Support for attending meetings from Novo Nordisk A/S. Advisory boards of Novo Nordisk A/S; Sanofi Aventis and Merck Sharp & Dohme. S.S.T.: research grant recipient Novo Nordisk. The remaining authors have no conflicts of interest to declare.

Trial registration number: The trial was approved by the Ethical Committee of the Capital Region of Denmark (H-16027082) and the Danish Medicines Agency (EudraCT Number: 2015-005585-32). ClinicalTrials.gov identifier (NCT number): NCT04122716.

Trial registration date: 11 May 2016.

Date of first patient’s enrolment: August 2016.

Keywords: GLP-1 agonist; liraglutide; male reproduction; obesity; semen quality; spermatozoa; weight loss.

© The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology.

Figures

Figure 1.
Figure 1.
Schematic overview of the study design. The exercise program was designed to meet the World Health Organization (WHO) recommendations on physical activity for health of a minimum of 150 min per week of moderate-intensity aerobic physical activity or 75 min per week of vigorous-intensity aerobic physical activity, or an equivalent combination of both.
Figure 2.
Figure 2.
Effect of weight loss on semen parameters. Difference in semen parameters before (T0), and after an 8-week low-calorie diet-induced weight loss (T1) in men with obesity (n = 47). Differences between groups were calculated with Student’s t-test. *P < 0.05 versus T0.
Figure 3.
Figure 3.
Substantial maintenance of weight loss after 52 weeks is associated with improved sperm concentration and sperm count. Difference in semen parameters after an 8-week low-calorie diet-induced weight loss followed by 52 weeks intervention (T2) compared to baseline (T0). Groups were based on weight loss after 52 weeks. Poor maintainers (red) had a weight loss of less than 11.7 kg after 52 weeks (n = 19). Good maintainers (blue) had a weight loss of more than 11.7 kg after 52 weeks (n = 18). Differences between groups were calculated with mixed-effects analysis using Turkey’s multiple comparisons test. Black bars indicate 95% CIs. Dots indicate individual observations. *P = <0.05 versus T0.

References

    1. Andersen JM, Herning H, Aschim EL, Hjelmesæth J, Mala T, Hanevik HI, Bungum M, Haugen TB, Witczak O.. Body mass index is associated with impaired semen characteristics and reduced levels of anti-Müllerian hormone across a wide weight range. PLoS One 2015;10:e0130210.
    1. Bentham J, Cesare M, Di Bilano V, Bixby H, Zhou B, Stevens GA, Riley LM, Taddei C, Hajifathalian K, Lu Y. et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet 2017;390:2627–2642.
    1. Best D, Avenell A, Bhattacharya S.. How effective are weight-loss interventions for improving fertility in women and men who are overweight or obese? A systematic review and meta-analysis of the evidence. Hum Reprod Update 2017;23:681–705.
    1. Brazil C, Swan SH, Tollner CR, Treece C, Drobnis EZ, Wang C, Redmon JB, Overstreet JW; Study for Future Families Research Group. Quality control of laboratory methods for semen evaluation in a multicenter research study. J Androl 2004;25:645–656.
    1. Carlsen E, Giwercman A, Keiding N, Skakkebaek NE.. Evidence for decreasing quality of semen during past 50 years. BMJ 1992;305:609–613.
    1. Cooper TG, Brazil C, Swan SH, Overstreet JW.. Ejaculate volume is seriously underestimated when semen is pipetted or decanted into cylinders from the collection vessel. J Androl 2007;28:1–4.
    1. Faure C, Dupont C, Baraibar MA, Ladouce R, Cedrin-Durnerin I, Wolf JP, Lévy R.. In subfertile couple, abdominal fat loss in men is associated with improvement of sperm quality and pregnancy: a case-series. In Volle DH, editor. PLoS One 2014;9:e86300.
    1. Fontoura P, Cardoso M. C D A, Erthal-Martins MC, Werneck C, Sartorio C, Ramos CF.. The effects of liraglutide on male fertility: a case report. Reprod Biomed Online 2014;29:644–646.
    1. Håkonsen LB, Thulstrup AM, Aggerholm AS, Olsen J, Bonde JP, Andersen CY, Bungum M, Ernst EH, Hansen ML, Ernst EH. et al. Does weight loss improve semen quality and reproductive hormones? Results from a cohort of severely obese men. Reprod Health 2011;8:24.
    1. Hernáez Á, Rogne T, Skåra KH, Håberg SE, Page CM, Fraser A, Burgess S, Lawlor DA, Magnus MC.. Body mass index and subfertility: multivariable regression and Mendelian randomization analyses in the Norwegian Mother, Father and Child Cohort Study. Hum Reprod 2021;36:3141–3151.
    1. Iwamoto T, Nozawa S, Yoshiike M, Hoshino T, Baba K, Matsushita T, Tanaka SN, Naka M, Skakkebæk NE, Jørgensen N.. Semen quality of 324 fertile Japanese men. Hum Reprod 2006;21:760–765.
    1. Jensen SBK, Lundgren JR, Janus C, Juhl CR, Olsen LM, Rosenkilde M, Holst JJ, Stallknecht BM, Madsbad S, Torekov SS.. Protocol for a randomised controlled trial of the combined effects of the GLP-1 receptor agonist liraglutide and exercise on maintenance of weight loss and health after a very low-calorie diet. BMJ Open 2019;9:e031431.
    1. Lazaros L, Hatzi E, Markoula S, Takenaka A, Sofikitis N, Zikopoulos K, Georgiou I.. Dramatic reduction in sperm parameters following bariatric surgery: report of two cases. Andrologia 2012;44:428–432.
    1. Levine H, Jørgensen N, Martino-Andrade A, Mendiola J, Weksler-Derri D, Mindlis I, Pinotti R, Swan SH.. Temporal trends in sperm count: a systematic review and meta-regression analysis. Hum Reprod Update 2017;23:646–659.
    1. Lundgren JR, Janus C, Jensen SBK, Juhl CR, Olsen LM, Christensen RM, Svane MS, Bandholm T, Bojsen-Møller KN, Blond MB. et al. Healthy weight loss maintenance with exercise, liraglutide, or both combined. N Engl J Med 2021;384:1719–1730.
    1. Mir J, Franken D, Andrabi SW, Ashraf M, Rao K.. Impact of weight loss on sperm DNA integrity in obese men. Andrologia 2018;50:e12957.
    1. Pärn T, Ruiz RG, Kallak TK, Ruiz JR, Davey E, Hreinsson J, Wånggren K, Salumets A, Sjöström M, Stavreus-Evers A. et al. Physical activity, fatness, educational level and snuff consumption as determinants of semen quality: findings of the ActiART study. Reprod Biomed Online 2015;31:108–119.
    1. Priskorn L, Nordkap L, Bang AK, Krause M, Holmboe SA, Egeberg Palme DL, Winge SB, Mørup N, Carlsen E, Joensen UN. et al. Average sperm count remains unchanged despite reduction in maternal smoking: results from a large cross-sectional study with annual investigations over 21 years. Hum Reprod 2018;33:998–1008.
    1. Rosety MÁ, Díaz AJ, Rosety JM, Pery MT, Brenes-Martín F, Bernardi M, García N, Rosety-Rodríguez M, Ordoñez FJ, Rosety I.. Exercise improved semen quality and reproductive hormone levels in sedentary obese adults. Nutr Hosp 2017;34:603–607.
    1. Salamun V, Jensterle M, Janez A, Vrtacnik Bokal E.. Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study. Eur J Endocrinol 2018;179:1–11.
    1. Salas-Huetos A, Maghsoumi-Norouzabad L, James ER, Carrell DT, Aston KI, Jenkins TG, Becerra-Tomás N, Javid AZ, Abed R, Torres PJ. et al. Male adiposity, sperm parameters and reproductive hormones: An updated systematic review and collaborative meta-analysis. Obes Rev 2021;22:e13082.
    1. Samavat J, Cantini G, Lotti F, Franco A, Di Tamburrino L, Degl’Innocenti S, Maseroli E, Filimberti E, Facchiano E, Lucchese M. et al. Massive weight loss obtained by bariatric surgery affects semen quality in morbid male obesity: a preliminary prospective double-armed study. Obes Surg 2018;28:69–76.
    1. Sermondade N, Faure C, Fezeu L, Shayeb AG, Bonde JP, Jensen TK, Wely M, Van Cao J, Martini AC, Eskandar M. et al. BMI in relation to sperm count: an updated systematic review and collaborative meta-analysis. Hum Reprod Update 2013;19:221–231.
    1. Slama R, Eustache F, Ducot B, Jensen TK, Jørgensen N, Horte A, Irvine S, Suominen J, Andersen AG, Auger J. et al. Time to pregnancy and semen parameters: a cross-sectional study among fertile couples from four European cities. Hum Reprod 2002;17:503–515.
    1. Sun B, Messerlian C, Sun Z-H, Duan P, Chen H-G, Chen Y-J, Wang P, Wang L, Meng T-Q, Wang Q. et al. Physical activity and sedentary time in relation to semen quality in healthy men screened as potential sperm donors. Hum Reprod 2019;34:2330–2339.
    1. World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen. 5th edn. Geneva: World Health Organization Press, 2010.
    1. Woodward B, Gossen N, Meadows J, Tomlinson M.. Uncertainty associated with assessing semen volume: are volumetric and gravimetric methods that different? Hum Fertil (Camb) 2016;19:249–253.

Source: PubMed

3
Iratkozz fel